Serum NfL levels were comparable between patients with stage I NSCLC and stage IV NSCLC without IMD (16 pg/mL and 20 pg/mL, respectively, p = 0.702), implying that disease stage does not influence serum NfL concentrations. This evidence concerns the gene NEFL and non-small cell lung carcinoma.